- Home
- INVA vs PDO Comparison
INVA vs PDO Comparison
Compare INVA & PDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$21.81
Company Overview
Basic Information| Metric | INVA | PDO |
|---|---|---|
| Founded | 1996 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | INVA | PDO |
|---|---|---|
| Price | $21.81 | $12.80 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $32.80 | N/A |
| AVG Volume (30 Days) | 527.8K | ★ 653.2K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.80% |
| EPS Growth | ★ 816.67 | N/A |
| EPS | ★ 2.22 | N/A |
| Revenue | ★ $217,217,000.00 | N/A |
| Revenue This Year | $8.95 | N/A |
| Revenue Next Year | $12.65 | N/A |
| P/E Ratio | $9.91 | ★ N/A |
| Revenue Growth | ★ 62.63 | N/A |
| 52 Week Low | $16.52 | $12.37 |
| 52 Week High | $25.15 | $14.25 |
Technical Indicators
Market Signals| Indicator | INVA | PDO |
|---|---|---|
| Relative Strength Index (RSI) | 37.26 | 31.60 |
| Support Level | $21.91 | $12.37 |
| Resistance Level | $22.76 | $14.13 |
| Average True Range (ATR) | 0.71 | 0.15 |
| MACD | -0.12 | -0.07 |
| Stochastic Oscillator | 7.69 | 18.75 |
Price Performance
Historical Comparison INVA
PDO
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
About PDO PIMCO Dynamic Income Opportunities Fund of Beneficial Interest
PIMCO Dynamic Income Opportunities Fund is a closed-end management investment company. The fund's primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities.